Laurus Labs Expands Capacity To Meet API Demand

As Company Looks To File Eight To Ten ANDAs Next Year

Laurus Labs has reported a 70% jump in annual revenues after what the company described as an “extraordinary year.” The firm has decided to expand its current capacities to meet the increased demand for third-party API sales and is looking to file eight to ten ANDAs next year as it sees “many long-term opportunities in the US generics space.”

Business Growth
Laurus Labs Reports Extraordinary FY21 • Source: Alamy

India’s Laurus Labs Ltd. says it is expanding its current capacities for key active pharmaceutical ingredients to meet increasing demand for third-party API sales, after the company saw an “extraordinary year” as it reported a 70% year on year jump in revenues to INR48.14bn ($652m) for its financial year ended 31 March 2021.

As Laurus registered a sales increase of INR19.81bn in a single financial year, founder and CEO Satyanarayana Chava also stated that the company is seeing many new opportunities in developed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Generics

More from Products